Steven Riley

Active 2003–2025

138
Papers
33,627
Citations
80
h-index
132
i10-index

Citations

Citations per year for Steven Riley1981: 2 citations1982: 1 citations1986: 1 citations1989: 1 citations1995: 1 citations1997: 1 citations1999: 1 citations2000: 1 citations2002: 1 citations2003: 52 citations2004: 102 citations2005: 92 citations2006: 126 citations2007: 126 citations2008: 104 citations2009: 151 citations2010: 190 citations2011: 185 citations2012: 135 citations2013: 181 citations2014: 143 citations2015: 175 citations2016: 143 citations2017: 139 citations2018: 136 citations2019: 336 citations2020: 3,270 citations2021: 2,661 citations2022: 1,276 citations2023: 547 citations2024: 662 citations2025: 244 citations2026: 25 citations1983–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown1990–1994: no citations, so these years are not shown1996: no citations, so this year is not shown1998: no citations, so this year is not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,253 citing papers, 20% of this breakdownUnited Kingdom: 2,111 citing papers, 13% of this breakdownChina: 1,128 citing papers, 6.9% of this breakdownItaly: 682 citing papers, 4.2% of this breakdownFrance: 561 citing papers, 3.5% of this breakdownAustralia: 546 citing papers, 3.4% of this breakdownCanada: 535 citing papers, 3.3% of this breakdownGermany: 534 citing papers, 3.3% of this breakdownIndia: 426 citing papers, 2.6% of this breakdownHong Kong: 413 citing papers, 2.5% of this breakdownSwitzerland: 365 citing papers, 2.2% of this breakdownNetherlands: 344 citing papers, 2.1% of this breakdown
0%20%Other 33%

Fields

  • Medicine44%
  • Mathematics33.5%
  • Computer Science3.2%
  • Immunology and Microbiology3.1%
  • Social Sciences2.9%
  • Psychology2.7%
  • Other10.6%

Topics

  • COVID-19 epidemiological studies16.4%
  • SARS-CoV-2 and COVID-19 Research8.6%
  • COVID-19 Clinical Research Studies6.4%
  • Influenza Virus Research Studies4.7%
  • Data-Driven Disease Surveillance3.1%
  • Viral Infections and Outbreaks Research2.7%
  • Other58.1%

Coauthors

All papers

Open in search
  1. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William D. Green, Timothy B. Hallett, Arran Hamlet, Wes Hinsley, B Jeffrey, Edward Knock, Daniel J. Laydon, Gemma Nedjati‐Gilani, Pierre Nouvellet, Kris V. Parag, Igor Siveroni, Hayley A Thompson, Robert Verity, Erik Volz, Caroline E. Walters, Haowei Wang, Yuanrong Wang, Oliver J. Watson, Peter Winskill, Xiaoyue Xi, Patrick Walker, Azra C. Ghani, Christl A. Donnelly, Steven Riley, Michaela Vollmer, Neil M. Ferguson, Lucy Okell, Samir Bhatt - Nature 2020 cited by 3,841

  2. Estimates of the severity of coronavirus disease 2019: a model-based analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christl A. Donnelly, Azra C. Ghani, Neil M. Ferguson - The Lancet Infectious Diseases 2020 cited by 4,164

  3. Persistent COVID-19 symptoms in a community study of 606,434 people in England

    Authors: , , , , , , , - Nature Communications 2022 cited by 440

  4. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A Ghani - 2020 cited by 3,766

  5. Global circulation patterns of seasonal influenza viruses vary with antigenic drift

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature, Nat. 2015 cited by 683

  6. Community transmission of monkeypox in the United Kingdom, April to May 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven Riley, Susan Hopkins - Eurosurveillance 2022 cited by 385

  7. Reduction in mobility and COVID-19 transmission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John A. Lees, Tara D. Mangal, Thomas A. Mellan, Gemma Nedjati‐Gilani, Kris V. Parag, Margarita Pons-Salort, Manon Ragonnet‐Cronin, Steven Riley, H. Juliette T. Unwin, Robert Verity, Michaela Vollmer, Erik Volz, Patrick Walker, Caroline E. Walters, Haowei Wang, Oliver J. Watson, Charles Whittaker, Lilith K. Whittles, Xiaoyue Xi, Neil M. Ferguson, Christl A. Donnelly - Nature Communications 2021 cited by 637

  8. Factors that make an infectious disease outbreak controllable

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 1,249

  9. Strategies for containing an emerging influenza pandemic in Southeast Asia

    Authors: , , , , , , , - Nature 2005 cited by 1,884

  10. Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China

    Authors: , , , , , , , , - PLoS Pathogens 2012 cited by 254

  11. Timescales of influenza A/H3N2 antibody dynamics

    Authors: , , , - PLoS Biology 2018 cited by 84

  12. Long-term evolution and transmission dynamics of swine influenza A virus

    Authors: , , , , , , , , , , , , , , , , - Nature 2011 cited by 262

  13. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data

    Authors: , , , , , , , - PLoS Biology 2015 cited by 184

  14. Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic

    Authors: , , , , , , , , , , - Emerging infectious diseases 2024 cited by 39

  15. Large-Scale Spatial-Transmission Models of Infectious Disease

    Authors: - Science 2007 cited by 628

  16. Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2021 cited by 86

  17. Population antibody responses following COVID-19 vaccination in 212,102 individuals

    Authors: , , , , , , , , , , , , , - Nature Communications 2022 cited by 165

  18. Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England

    Authors: , , , , , , , , , , , , - PLoS Biology 2023 cited by 36

  19. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic

    Authors: , , , , , , , , - Philosophical Transactions of the Royal Society B Biological Sciences 2004 cited by 531

  20. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

    Authors: , , , , , , , , , , , , , , , , , , , - Science 2021 cited by 190

  21. Evolutionary Dynamics and Emergence of Panzootic H5N1 Influenza Viruses

    Authors: , , , , , , , , - PLoS Pathogens 2008 cited by 186

  22. Spatial and temporal dynamics of superspreading events in the 2014–2015 West Africa Ebola epidemic

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 201

  23. Collaborative efforts to forecast seasonal influenza in the United States, 2015–2016

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katie Will, James Turtle, David Bacon, Steven Riley, Wan Yang - Scientific Reports 2019 cited by 145

  24. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people

    Authors: , , , , , , , , , - PLoS Medicine 2021 cited by 123